Literature DB >> 32556544

Sustained remission of giant pancreatic plasmacytoma with daratumumab.

Satoshi Ichikawa1, Eijiro Furukawa2, Kei Saito2, Noriko Fukuhara2, Koichi Onodera2, Yasushi Onishi2, Hisayuki Yokoyama2, Ryo Ichinohasama3, Hideo Harigae2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32556544     DOI： 10.1007/s00277-020-04145-9

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  4 in total

Review 1.  Extramedullary multiple myeloma.

Authors:  Manisha Bhutani; David M Foureau; Shebli Atrash; Peter M Voorhees; Saad Z Usmani
Journal:  Leukemia       Date:  2019-11-27       Impact factor: 11.528

2.  Hematogenous extramedullary relapse in multiple myeloma - a multicenter retrospective study in 127 patients.

Authors:  Irit Avivi; Yael C Cohen; Anna Suska; Tamir Shragai; Gabor Mikala; Laurent Garderet; Gueye M Seny; Sophia Glickman; David S Jayabalan; Ruben Niesvizky; Alessandro Gozzetti; Katarzyna Wiśniewska-Piąty; Anna Waszczuk-Gajda; Lidia Usnarska-Zubkiewicz; Iwona Hus; Renata Guzicka; Jakub Radocha; Vibor Milunovic; Julio Davila; Massimo Gentile; Jorge J Castillo; Artur Jurczyszyn
Journal:  Am J Hematol       Date:  2019-08-13       Impact factor: 10.047

3.  Daratumumab resistance is frequent in advanced-stage multiple myeloma patients irrespective of CD38 expression and is related to dismal prognosis.

Authors:  Marjorie Pick; Vladimir Vainstein; Neta Goldschmidt; David Lavie; Diana Libster; Alexander Gural; Sigal Grisariu; Batia Avni; Dina Ben Yehuda; Moshe E Gatt
Journal:  Eur J Haematol       Date:  2018-03-25       Impact factor: 2.997

Review 4.  How I treat extramedullary myeloma.

Authors:  Cyrille Touzeau; Philippe Moreau
Journal:  Blood       Date:  2015-12-17       Impact factor: 22.113
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.